Detalhe da pesquisa
1.
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
Cell
; 184(10): 2605-2617.e18, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33831372
2.
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
Cell
; 183(1): 143-157.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877699
3.
Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections.
Immunity
; 54(6): 1186-1199.e7, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915108
4.
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation.
Nature
; 615(7950): 143-150, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630998
5.
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
PLoS Pathog
; 20(4): e1011680, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635853
6.
HIV post-treatment controllers have distinct immunological and virological features.
Proc Natl Acad Sci U S A
; 120(11): e2218960120, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877848
7.
Characterization of treatment resistance and viral kinetics in the setting of single- versus dual-active monoclonal antibodies against SARS-CoV-2.
J Infect Dis
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716969
8.
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control.
J Virol
; 97(1): e0125422, 2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541802
9.
Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A3 adenosine receptor in HL-60 cells.
Purinergic Signal
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416332
10.
Long-term outcomes of PGA-TMC absorbable synthetic scaffold in both clean and contaminated ventral hernia repairs.
Surg Endosc
; 38(4): 2231-2239, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498213
11.
High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial.
Am J Respir Crit Care Med
; 208(12): 1293-1304, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774011
12.
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
Ann Intern Med
; 176(3): 348-354, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802755
13.
Profound Treg perturbations correlate with COVID-19 severity.
Proc Natl Acad Sci U S A
; 118(37)2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433692
14.
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study.
Ann Intern Med
; 176(12): 1577-1585, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956428
15.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Ann Intern Med
; 176(5): 658-666, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068272
16.
MR-linac MLC positioning QA by digitally stitching dual double-exposed films.
J Appl Clin Med Phys
; : e14325, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467039
17.
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
J Infect Dis
; 228(2): 133-142, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661240
18.
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
J Infect Dis
; 228(Suppl 2): S117-S125, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650230
19.
Variant-Specific Viral Kinetics in Acute COVID-19.
J Infect Dis
; 228(Suppl 2): S136-S143, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650233
20.
Immune Status and SARS-CoV-2 Viral Dynamics.
J Infect Dis
; 228(Suppl 2): S111-S116, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650232